Phar 7.11(3)(b)7.7. Quantity of the drug product or device prescribed, dispensed and remaining. Phar 7.11(3)(c)(c) The pharmacist shall be responsible for attempting to ascertain and record any patient allergies, adverse drug reactions, drug idiosyncrasies, and any chronic conditions which may affect drug therapy as communicated by the patient or agent of the patient. If none, this should be indicated. Phar 7.11(3)(d)(d) Medication profile records shall be maintained for a minimum period of 5 years following the date of the last dispensing. Phar 7.11 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (1), (3) (b) 3. made under s. 35.17, Stats., Register December 2020 No. 780. Phar 7.12Phar 7.12 Delegation by a physician. The pharmacist shall document the delegation by a physician under s. 450.033, Stats. The delegated act may not be started prior to the documentation. The documentation shall be maintained for a minimum of 5 years after the last delegated act under that delegation. Phar 7.12 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction made under s. 35.17, Stats., Register December 2020 No. 780. Phar 7.13Phar 7.13 Administration of drug products and devices other than vaccines. Phar 7.13(1)(1) In this section, “course of study” means one or more classes, workshops, seminars, or continuing education programs. Phar 7.13(2)(2) A pharmacist may administer a drug product, as defined in s. 450.01 (11), Stats., or device, as defined in s. 450.01 (6), Stats. After the pharmacist administers a prescribed drug product or device, the pharmacist, a person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g), Stats., or the pharmacist’s agent shall notify the prescribing practitioner or enter the information in a patient record system shared by the prescribing practitioner. Phar 7.13(3)(3) A pharmacist may not administer by injection a prescribed drug product or device unless the pharmacist has successfully completed a course of study and training in administration technique conducted by a course provider approved by the Accreditation Council for Pharmacy Education or the board. Phar 7.13(4)(4) A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g), Stats., may not administer a prescribed drug product or device unless the person satisfies all of the following: Phar 7.13(4)(a)(a) Successfully completes a course of study and training in administration technique conducted by a course provider approved by the Accreditation Council for Pharmacy Education or the board. Phar 7.13(4)(b)(b) Administers the prescribed drug product or device only under the direct supervision of a pharmacist who has successfully completed a course of study and training in administration technique conducted by a course provider approved by the Accreditation Council of Pharmacy Education or the board. Phar 7.13(4)(c)(c) After administering the prescribed drug product or device, notifies the prescribing practitioner or enters the information in a patient record system shared by the prescribing practitioner. Phar 7.13(5)(5) The board may approve courses of study which meet criteria substantially equivalent to criteria used by the Accreditation Council for Pharmacy Education. Phar 7.13(6)(6) A course of study and training in administration technique shall include all of the following topics: Phar 7.13(6)(d)(d) The 5 rights of administration including right patient, right drug, right dose, right route, and right time. Phar 7.13(6)(e)(e) Patient reassessment after administration including signs and symptoms of adverse drug reactions. Phar 7.13(6)(f)(f) Best practices in documentation of the medication administration.